GSK1059865

GSK1059865 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:GSK1059865
CAS:1191044-58-2
Purity:98.00% Package:1 mL * 10mM (in DMSO);10 mg;100 mg;2 mg;200 mg;25 mg;5 mg;50 mg;500 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105
Email: sales@invivochem.cn
Products Intro: Product Name:GSK1059865 HCl
CAS:1191044-58-2
Purity:98% Package:5mg Remarks:V3446
Company Name: Shenyang Zhongshen Zekang Biomedical Technology Research Co., Ltd
Tel: +86-18341751992 +86-15382112998
Email: 757984502@qq.com
Products Intro: Product Name:GSK1059865
CAS:1191044-58-2
Purity:98 Package:500mg;1g;5g;10g;25g Remarks:Provide customized services
Company Name: Aladdin Scientific
Tel: +1-+1(833)-552-7181
Email: sales@aladdinsci.com
Products Intro: Product Name:GSK1059865
CAS:1191044-58-2
Purity:99% Package:$100.9/2mg;$192.9/5mg;$324.9/10mg;$684.9/25mg;$1152.9/50mg;$2040.9/100mg;Bulk pa Remarks:99%
Company Name: Pharmacodia (Beijing) Co.,Ltd  
Tel: +86-400-851-9921
Email: sales@pharmacodia.com
Products Intro: Product Name:GSK1059865
CAS:1191044-58-2
Package:10Mg-100g
GSK1059865 Basic information
Product Name:GSK1059865
Synonyms:GSK1059865;GSK-1059865 (GSK 1059865;Methanone, [(2S,5S)-2-[[(5-bromo-2-pyridinyl)amino]methyl]-5-methyl-1-piperidinyl](3-fluoro-2-methoxyphenyl)-;GSK1059865 HCl;((2S,5S)-2-(((5-Bromopyridin-2-yl)amino)methyl)-5-methylpiperidin-1-yl)(3-fluoro-2-methoxyphenyl)methanone
CAS:1191044-58-2
MF:C20H23BrFN3O2
MW:436.32
EINECS:
Product Categories:
Mol File:1191044-58-2.mol
GSK1059865 Structure
GSK1059865 Chemical Properties
Boiling point 575.8±50.0 °C(Predicted)
density 1.376±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : ≥ 50 mg/mL (114.59 mM)
form Solid
pka4.89±0.10(Predicted)
color White to off-white
Safety Information
MSDS Information
GSK1059865 Usage And Synthesis
Biological ActivityGSK1059865 is a potent orexin 1 receptor antagonist.
in vivo

Treatment with GSK1059865 significantly decreases ethanol drinking in a dose-dependent manner in CIE-exposed mice. In contrast GSK1059865 decreases drinking in air-exposed mice only at the highest dose used. There is no effect of GSK1059865 on sucrose intake. GSK1059865 (0.3 nM-10 nM) produces non-surmountable antagonism with a dose-dependent rightward shift of the OXA EC 50 and a concomitant decrease of the agonist maximal response. The calculated pK B value is 8.77±0.12 for GSK1059865. GSK1059865 (0.1-3.3 μM) produces a classical surmountable profile with parallel rightward shift of the OXA EC 50 without depression of the agonist maximal response. Intraperitoneal The administration of GSK1059865 produces a region-dependent inhibition of yohimbine-induced relative cerebral blood volume response. The administration of GSK1059865 per se produces a weak relative cerebral blood volume increase in several brain regions. GSK1059865-pretreated ani mals exhibit slightly higher baseline mean arterial blood pressure values than controls.

target

Orexin 1 receptor

GSK1059865 Preparation Products And Raw materials
Tag:GSK1059865(1191044-58-2) Related Product Information